Literature DB >> 27798150

Epigenetic Regulation of Early- and Late-Response Genes in Acute Pancreatitis.

Juan Sandoval1, Javier Pereda2, Salvador Pérez2, Isabela Finamor2, Azahara Vallet-Sánchez1,3, José Luis Rodríguez1, Luis Franco1,3, Juan Sastre4, Gerardo López-Rodas1,3.   

Abstract

Chromatin remodeling seems to regulate the patterns of proinflammatory genes. Our aim was to provide new insights into the epigenetic mechanisms that control transcriptional activation of early- and late-response genes in initiation and development of severe acute pancreatitis as a model of acute inflammation. Chromatin changes were studied by chromatin immunoprecipitation analysis, nucleosome positioning, and determination of histone modifications in promoters of proinflammatory genes in vivo in the course of taurocholate-induced necrotizing pancreatitis in rats and in vitro in rat pancreatic AR42J acinar cells stimulated with taurocholate or TNF-α. Here we show that the upregulation of early and late inflammatory genes rely on histone acetylation associated with recruitment of histone acetyltransferase CBP. Chromatin remodeling of early genes during the inflammatory response in vivo is characterized by a rapid and transient increase in H3K14ac, H3K27ac, and H4K5ac as well as by recruitment of chromatin-remodeling complex containing BRG-1. Chromatin remodeling in late genes is characterized by a late and marked increase in histone methylation, particularly in H3K4. JNK and p38 MAPK drive the recruitment of transcription factors and the subsequent upregulation of early and late inflammatory genes, which is associated with nuclear translocation of the early gene Egr-1 In conclusion, specific and strictly ordered epigenetic markers such as histone acetylation and methylation, as well as recruitment of BRG-1-containing remodeling complex are associated with the upregulation of both early and late proinflammatory genes in acute pancreatitis. Our findings highlight the importance of epigenetic regulatory mechanisms in the control of the inflammatory cascade.
Copyright © 2016 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27798150     DOI: 10.4049/jimmunol.1502378

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  8 in total

1.  Glycosylation alterations in acute pancreatitis and pancreatic cancer: CA19-9 expression is involved in pathogenesis and maybe targeted by therapy.

Authors:  Ionut Negoi; Mircea Beuran; Sorin Hostiuc; Massimo Sartelli; Alaa El-Hussuna; Enrique de-Madaria
Journal:  Ann Transl Med       Date:  2019-12

2.  Decoding Cinnabarinic Acid-Specific Stanniocalcin 2 Induction by Aryl Hydrocarbon Receptor.

Authors:  Nikhil Y Patil; Hui Tang; Iulia Rus; Kangling Zhang; Aditya D Joshi
Journal:  Mol Pharmacol       Date:  2021-11-11       Impact factor: 4.436

3.  N-n-Butyl Haloperidol Iodide, a Derivative of the Anti-psychotic Haloperidol, Antagonizes Hypoxia/Reoxygenation Injury by Inhibiting an Egr-1/ROS Positive Feedback Loop in H9c2 Cells.

Authors:  Ting Sun; Yanmei Zhang; Shuping Zhong; Fenfei Gao; Yicun Chen; Bin Wang; Wenfeng Cai; Zhaojing Zhang; Weiqiu Li; Shishi Lu; Fuchun Zheng; Ganggang Shi
Journal:  Front Pharmacol       Date:  2018-01-25       Impact factor: 5.810

4.  Blockade of the trans-sulfuration pathway in acute pancreatitis due to nitration of cystathionine β-synthase.

Authors:  Sergio Rius-Pérez; Salvador Pérez; Isabel Torres-Cuevas; Pablo Martí-Andrés; Raquel Taléns-Visconti; Alberto Paradela; Laura Guerrero; Luis Franco; Gerardo López-Rodas; Luis Torres; Fernando Corrales; Juan Sastre
Journal:  Redox Biol       Date:  2019-09-08       Impact factor: 11.799

5.  Effects of Egr1 on pancreatic acinar intracellular trypsinogen activation and the associated ceRNA network.

Authors:  Bo Gao; Xueming Zhang; Dongbo Xue; Weihui Zhang
Journal:  Mol Med Rep       Date:  2020-07-09       Impact factor: 2.952

6.  Transcriptional response of human articular chondrocytes treated with fibronectin fragments: an in vitro model of the osteoarthritis phenotype.

Authors:  K S M Reed; V Ulici; C Kim; S Chubinskaya; R F Loeser; D H Phanstiel
Journal:  Osteoarthritis Cartilage       Date:  2020-11-25       Impact factor: 6.576

7.  Evaluating the bromodomain protein BRD1 as a therapeutic target in rheumatoid arthritis.

Authors:  Kerstin Klein; Masaru Kato; Mojca Frank-Bertoncelj; Christoph Kolling; Adrian Ciurea; Steffen Gay; Caroline Ospelt
Journal:  Sci Rep       Date:  2018-07-24       Impact factor: 4.379

8.  miR‑92a‑3p regulates trypsinogen activation via Egr1 in AR42J cells.

Authors:  Xueming Zhang; Bo Gao; Yang Huang; Yong Zhang; Zhituo Li; Dali Zhao; Biao Ma; Dongbo Xue; Weihui Zhang
Journal:  Mol Med Rep       Date:  2019-09-11       Impact factor: 2.952

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.